Is rosacea a systemic disease?

被引:35
|
作者
Wollina, Uwe [1 ]
机构
[1] Acad Teaching Hosp, Stadt Klinikum Dresden, Dept Dermatol & Allergol, Dresden, Germany
关键词
CARDIOVASCULAR-DISEASE; INCREASED RISK; DISORDERS; DEPRESSION; ANXIETY; COMORBIDITIES; POPULATION; EXPRESSION; RHINOPHYMA; CANCER;
D O I
10.1016/j.clindermatol.2019.07.032
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Rosacea is a chronic inflammatory facial disease occurring world-wide. The incidence of rosacea is increasing with age, with the clinical course being characterized by relapses. The pathogenesis of rosacea is not completely understood, but neurovascular and immunologic mechanisms are involved. Rosacea has a number of known extrinsic triggers that should be avoided, such as sun exposure, heat and cold, alcoholic beverages, and spicy food. Of greater importance is the observation that rosacea may develop as a manifestation of systemic diseases with a significant morbidity and even mortality. Obesity, Helicobacter pylori infection, smoking, and inflammatory bowel disease bear a significant risk for the development of rosacea. Metabolic, psychiatric, and neurologic disorders and certain types of cancer show a significant association with rosacea. The possible link to cardiovascular events is debatable. There are extrafacial and extracutaneous manifestations of rosacea, such as the red scalp syndrome, ocular rosacea, and migraine. Rosacea should be considered a systemic disease. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:629 / 635
页数:7
相关论文
共 50 条
  • [1] Rosacea, not just skin deep: Understanding the systemic disease burden
    Morss-Walton, Peyton
    McGee, Jean S.
    [J]. CLINICS IN DERMATOLOGY, 2021, 39 (04) : 695 - 700
  • [2] Systemic therapy of rosacea
    Schaller, M.
    Belge, K.
    [J]. HAUTARZT, 2013, 64 (07): : 500 - 505
  • [3] Systemic treatment of rosacea with isotretinoin
    Jansen, T
    Plewig, G
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (50) : 1745 - 1747
  • [4] Rosacea Part II. Topical and systemic therapies in the treatment of rosacea
    Two, Aimee M.
    Wu, Wiggin
    Gallo, Richard L.
    Hata, Tissa R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : 761 - 770
  • [5] State of the art: Systemic rosacea management
    Schaller, M.
    Schoefer, H.
    Homey, B.
    Gieler, U.
    Lehmann, P.
    Luger, T. A.
    Ruzicka, T.
    Steinhoff, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (S 16): : 29 - 37
  • [6] Rosacea and acne: topical or systemic treatment?
    Lehmann, P.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (28-29) : 1435 - 1439
  • [7] Current topical and systemic approaches to treatment of rosacea
    Korting, H. C.
    Schoellmann, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (08) : 876 - 882
  • [8] Systemic therapy of ocular and cutaneous rosacea in children
    Gonser, L. I.
    Gonser, C. E.
    Deuter, C.
    Heister, M.
    Zierhut, M.
    Schaller, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (10) : 1732 - 1738
  • [9] Rosacea and Dry Eye Disease
    Sobolewska, Bianka
    Schaller, Martin
    Zierhut, Manfred
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (03) : 570 - 579
  • [10] Rosacea and cardiovascular disease: Is there an association?
    Dosal, Jacquelyn
    Keri, Jonette
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 308 - 309